BR9908623A - Uso de antagonistas de alfa-rar para a inibição da secreção de mucina - Google Patents

Uso de antagonistas de alfa-rar para a inibição da secreção de mucina

Info

Publication number
BR9908623A
BR9908623A BR9908623-9A BR9908623A BR9908623A BR 9908623 A BR9908623 A BR 9908623A BR 9908623 A BR9908623 A BR 9908623A BR 9908623 A BR9908623 A BR 9908623A
Authority
BR
Brazil
Prior art keywords
rar
antagonist
alpha
mucin secretion
rar antagonists
Prior art date
Application number
BR9908623-9A
Other languages
English (en)
Inventor
Paula Nanette Belloni
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9908623A publication Critical patent/BR9908623A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Patente de Invenção: <B>"USO DE ANTAGONISTAS DE ALFA-RAR PARA A INIBIçãO DA SECREçãO DE MUCINA"<D>. A presente invenção está relacionada ao uso de um antagonista de RAR para a inibição da produção de mucina em um mamífero. De preferência, o antagonista de RAR é um antagonista seletivo de RAR<244>. Em outro aspecto, a presente invenção está relacionada à inibição da expressão do gene de mucina em uma célula epitelial humana através de contato da célula com um antagonista de RAR, de preferência um antagonista seletivo de RAR<244>.
BR9908623-9A 1998-03-09 1999-03-01 Uso de antagonistas de alfa-rar para a inibição da secreção de mucina BR9908623A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7732898P 1998-03-09 1998-03-09
PCT/EP1999/001328 WO1999045915A1 (en) 1998-03-09 1999-03-01 Use of alpha-rar antagonists for inhibition of mucin secretion

Publications (1)

Publication Number Publication Date
BR9908623A true BR9908623A (pt) 2000-11-14

Family

ID=22137426

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908623-9A BR9908623A (pt) 1998-03-09 1999-03-01 Uso de antagonistas de alfa-rar para a inibição da secreção de mucina

Country Status (12)

Country Link
US (1) US6083973A (pt)
EP (1) EP1061910A1 (pt)
JP (1) JP2002506025A (pt)
KR (1) KR100386349B1 (pt)
CN (1) CN1169524C (pt)
AR (1) AR017726A1 (pt)
AU (1) AU735382B2 (pt)
BR (1) BR9908623A (pt)
CA (1) CA2321935A1 (pt)
TR (1) TR200002587T2 (pt)
WO (1) WO1999045915A1 (pt)
ZA (1) ZA991852B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4225500A (en) * 1999-04-14 2000-11-14 Allergan Sales, Inc. Methods and compositions for the treatment and prevention of lung disease
US6436993B1 (en) * 1999-07-13 2002-08-20 The Salk Institute For Biological Studies Use of RAR antagonists as modulators of hormone mediated processes
JO2178B1 (en) * 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of emphysema using rar selective retinoid antagonists
US6713515B2 (en) * 2000-09-13 2004-03-30 Bristol Myers Squibb Company Retinoic acid receptor antagonists as promoters of angiogenesis
ATE525398T1 (de) * 2002-05-10 2011-10-15 Medimmune Inc Epha2 monoklonale antikörper und deren anwendungsverfahren
JP4585968B2 (ja) * 2002-05-10 2010-11-24 パーデュー・リサーチ・ファウンデーション ＥｐｈＡ２アゴニストモノクローナル抗体およびその使用法
US20050152899A1 (en) * 2002-05-10 2005-07-14 Kinch Michael S. EphA2 agonistic monoclonal antibodies and methods of use thereof
WO2004091375A2 (en) * 2003-04-11 2004-10-28 Medimmune, Inc. Epha2 and non-neoplastic hyperproliferative cell disorders
US20080146915A1 (en) * 2006-10-19 2008-06-19 Mcmorrow Gerald Systems and methods for visualizing a cannula trajectory
CN107176945B (zh) * 2016-03-11 2021-06-08 中国科学院上海有机化学研究所 一种视黄酸类化合物、其制备方法、中间体及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2093577C (en) * 1992-05-07 2006-01-03 Michael Klaus Alkyl or alkoxy substituted s-heterocyclic retinoids
US5807900A (en) * 1995-03-31 1998-09-15 Hoffmann-La Roche, Inc. Method for identifying compounds having increased activity for the repair of skin photodamage
CA2233012A1 (en) * 1995-09-21 1997-03-27 Koichi Shudo Compounds enhancing the activity of retinoids
FR2739557B1 (fr) * 1995-10-09 1997-11-14 Cird Galderma Utilisation d'un ligand agoniste specifique rar-gamma
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity

Also Published As

Publication number Publication date
AR017726A1 (es) 2001-09-12
CN1292690A (zh) 2001-04-25
US6083973A (en) 2000-07-04
AU2727399A (en) 1999-09-27
ZA991852B (en) 1999-09-09
EP1061910A1 (en) 2000-12-27
KR100386349B1 (ko) 2003-06-02
WO1999045915A1 (en) 1999-09-16
JP2002506025A (ja) 2002-02-26
TR200002587T2 (tr) 2000-11-21
AU735382B2 (en) 2001-07-05
KR20010041720A (ko) 2001-05-25
CA2321935A1 (en) 1999-09-16
CN1169524C (zh) 2004-10-06

Similar Documents

Publication Publication Date Title
BR9908623A (pt) Uso de antagonistas de alfa-rar para a inibição da secreção de mucina
BR0004382A (pt) Partìculas revestidas de óxido misto de lìtio e sua utilização ii
YU45293A (sh) Morfolin i tiomorfolin tahikinin antagonisti receptora
NO20026252D0 (no) AZA-broforbundet - bicykliske aminosyrederivater som alfa 4 integrin antagonister
DE69932032D1 (de) Inhibitoren der alpha4 vermittelten zelladhäsion
PT1062962E (pt) Dispensador de farmaco do tipo inalador
SG151254A1 (en) Substituted morpholine and thiomorpholine derivatives
AU2002221528A1 (en) Use of hyaluronic acid derivatives for the prevention of inflammatory arthritis
EP1476121A4 (en) TOPICAL IVERMECTIN COMPOSITION
EP1113000A4 (en) BENZENE DERIVATIVES AND THEIR MEDICAL APPLICATION
AR021934A1 (es) Composicion de administracion oral con liberacion controlada de al menos un analgesico
SI1079843T1 (sl) Uporaba inhibitorjev receptorja alfa1beta1-integrina in inhibitorjev TGF-beta1 pri zdravljenju ledvične bolezni
ATE235242T1 (de) Orale arzneiformen mit reproduzierbarer wirkstofffreisetzung von gatifloxacin oder pharmazeutisch verwendbaren salzen oder hydraten
BR9811465A (pt) N-triazolil-2-indolcarboxamidas e sua utilização como agonistas de cck-a.
BR9907733A (pt) Antagonistas vla-4
ITMI992107A0 (it) Uso del baclofen nel trattamento dell&#39;astinenza da etanolo
PT1080274E (pt) Relva artificial com hastes ocas
AU2672500A (en) Systemic use of 5-ht3 receptor antagonists against rheumatic inflammatory processes
AR028431A1 (es) Combinacion de agentes fitoprotectores con polimeros formadores de puentes de hidrogeno
AU4856600A (en) Use of agonists or antagonists of the 5-ht7 receptor to treat disorders of the bladder
BR0114677A (pt) Inibição da dependência de fator de crescimento de células de tumores
PA8511401A1 (es) Nuevos derivados de amidas heterociclicas
BR0013778A (pt) Uso de leptina na inibição de proliferação de célula endotelial
ITRM990728A0 (it) Composizione per stimolare l&#39;interruzione della dormienza delle gemmedei fruttiferi e relativo uso.
IT1299082B1 (it) Composizione per l&#39;igiene orale per uso nella facilitazione dell&#39;insorgenza del sonno

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 31/20, A61K 31/382, A61K 31/19, A61K 31/352, A61K 31/551, A61K 31/4184,A61P 11/00, A61P 11/06, A61P 43/00

Ipc: A61K 31/20 (2008.01), A61K 31/35 (2008.01), A61K 3

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DE ACORDO COM ART. 8O DA LPI.